Wegovy Oral
oral semaglutide · made by Novo Nordisk · FDA approved 2025
Last updated July 2026 · TrimSoMo Editorial Team
Where to Get Wegovy Oral
Three routes, three trade-offs. Ranges below are typical 2026 cash prices — for the exact current Wegovy Oral breakdown, see the Wegovy Oral cost guide →
- · Guaranteed authentic supply
- · 2026 direct-to-consumer pricing (oral from ~$150, injectable ~$350)
- · Requires a valid prescription
- · Online consultation included
- · Insurance & prior-auth support
- · Ongoing dose & side-effect guidance
- · Limited to documented medical need (post-shortage FDA rules)
- · 503A/503B pharmacies only
- · Choose LegitScript-verified clinics
Find a Wegovy Oral Clinic Near You
Browse GLP-1 clinics across 558 U.S. metro areas and filter for those that list Wegovy Oral — with LegitScript and FDA status surfaced on each listing.
Compare Alternatives
Wegovy Oral — Frequently Asked Questions
How much does Wegovy Oral cost in 2026?
Wegovy Oral cash prices typically range from about $150/mo for oral manufacturer-direct options to $1,000+/mo for brand injectable without insurance. Telehealth platforms commonly land between $250–$550/mo. See the Wegovy Oral cost guide for the current breakdown.
Where can I buy Wegovy Oral?
There are three routes: manufacturer direct (guaranteed authentic, requires a prescription), telehealth platforms (consultation, insurance and prior-auth support included), and compounded alternatives (restricted in 2026 to documented medical need via 503A/503B pharmacies). Choose LegitScript-verified clinics.
Does insurance cover Wegovy Oral?
Many major plans cover Wegovy Oral with prior authorization, typically when BMI ≥ 30 (or ≥ 27 with a weight-related condition). Coverage varies by plan; a clinic with prior-auth support can check your specific benefits.
Related guides
The FDA approved the first oral GLP-1 weight-loss drug — a once-daily Wegovy pill. Here's how it works, the $150/month price, the empty-stomach catch, and whether to switch from injections.
Orforglipron is Eli Lilly's once-daily GLP-1 pill expected to hit the U.S. in 2026. How it differs from the Wegovy pill, why no empty-stomach rule is a big deal, and what it could mean for prices.
After the FDA declared the semaglutide shortage over, the rules for compounded GLP-1s changed. Here's what's actually allowed in 2026, why your cheap compounded program may have stopped, and how to stay safe.
Nausea, constipation, and 'sulfur burps' are the most common GLP-1 side effects. Practical, doctor-aligned tips to reduce them — plus the warning signs that mean you should call your provider.